VERSES Names Renowned AI and Public Sector Leader Dr. David Bray to Chair Strategic Advisory Council
VANCOUVER, British Columbia — June 10, 2025 — VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, today announced the appointment of Dr. David Bray, Ph.D., as Chair of its newly formed Strategic Advisory Council. As Strategic Advisory Chair, Dr. David Bray is expected to assist the Company in assembling a council of experts across industry, policy, and technology, aimed at accelerating the Company’s strategic growth and driving market adoption across both private and public sectors.
Dr. Bray is a globally recognized expert on AI, data, and cybersecurity. He was named one of the “Top 24 Americans Changing the World” by Business Insider for his leadership in turbulent environments, national security, digital transformations, counter-bioterrorism, and public health. Dr. Bray has held executive roles across government, academia, and industry, he also led two successful bipartisan commissions on the future of AI, cybersecurity, biotechnology, commercial space endeavors, and quantum computing.
Dr. Bray previously served as IT Chief for the Bioterrorism Preparedness and Response Program during the responses to 9/11, anthrax, SARS, and other events; as well as Senior Executive and CIO of the FCC, a Senior National Intelligence Service Executive, and as a strategic advisor to multinational organizations navigating emerging technologies and complex global challenges. In 2023 he was elected as a member of the National Academy of Public Administration. He also received the Global CIO 100 award twice (2015, 2017)
“We are honored to have David on board to provide guidance and to lead our Strategic Advisory Council,” said Gabriel René, CEO of VERSES. “David brings a rare mix of public and private leadership, scientific acumen, and systems-level thinking. His impressive track record working at the intersection of emerging technology, national security, and policy makes him the ideal Chair for our Advisory Council. We very much appreciate his leadership in helping to drive our global growth strategy.”
“I'm energized to help VERSES scale its technology to enhance the speed of decisions, adaptability, and resiliency of both companies and communities alike,” said Dr. David Bray. “Having navigated numerous high-stakes environments, from protecting national security, to managing global health emergencies, to shaping the future of space systems, I've seen firsthand how complex challenges require systems that adapt quickly to a changing world, and in those moments, the ability to make swift, informed decisions with limited information is critical. What excites me about VERSES’ Active Inference technology is that it is designed to help companies, communities, and countries make better decisions with less information, and it does so efficiently, bringing intelligence to the edge; right where it’s needed most.”
Dr Bray currently serves as Chair of the Accelerator and Distinguished Fellow at the Stimson Center, Senior Fellow at the Institute for Human-Machine Cognition, and is an expert affiliated with MIT Horizon, the Oxford Internet Institute, and Harvard’s Leadership for a Networked World Program. In 2019, the United Nations invited him to give the Distinguished AI address on Charter Day. He was also awarded the National Intelligence Exceptional Achievement Medal in 2013.
About VERSES
VERSES® is a cognitive computing company building next-generation intelligent software systems modeled after the wisdom and genius of Nature. Designed around first principles found in science, physics and biology, our flagship product, Genius,™ is an agentic enterprise intelligence platform designed to generate reliable domain-specific predictions and decisions under uncertainty. Imagine a Smarter World that elevates human potential through technology inspired by Nature. Learn more at verses.ai, LinkedIn and X.
On behalf of the Company
Gabriel René, Founder & CEO, VERSES AI Inc.
Press Inquiries: press@verses.ai
Investor Relations Inquiries
James Christodoulou, Chief Financial Officer
IR@verses.ai, +1(212)970-8889
Cautionary Note Regarding Forward-Looking Statements
This news release contains statements which constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and plans of the Company. Forward-looking information and forward-looking statements are often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions. More particularly and without limitation, this news release contains forward–looking statements and information relating to the expectation that Dr. Bray will assist the Company in assembling a council of experts across industry, policy, and technology, aimed at accelerating the Company’s strategic growth and driving market adoption across both private and public sectors; the expectation that Active Inference technology will put the power to make more reliable predictions with incomplete information into the hands of companies, communities, and countries; and other statements that are not historical facts.
The forward–looking statements and information are based on certain key expectations and assumptions made by the management of the Company. As a result, there can be no assurance that such plans will be completed as proposed or at all. Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that Dr. Bray will successfully assist the Company in assembling a council of experts across industry, policy, and technology, aimed at accelerating the Company’s strategic growth and driving market adoption across both private and public sectors; that Active Inference technology will put the power to make more reliable predictions with incomplete information into the hands of companies, communities, and countries. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward–looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward–looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, that Dr. Bray will not successfully assist the Company in assembling a council of experts across industry, policy, and technology, aimed at accelerating the Company’s strategic growth and driving market adoption across both private and public sectors or at all; that Active Inference technology will not successfully put the power to make more reliable predictions with incomplete information into the hands of companies, communities, and countries and other risks detailed from time to time in the filings made by the Company in accordance with securities regulations. Accordingly, readers should not place undue reliance on the forward–looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward–looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward–looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.